Sorry, you need to enable JavaScript to visit this website.

Safety and Efficacy Study of Enzalutamide Versus Bicalutamide in Men With Prostate Cancer (STRIVE)

STRIVE: A Multicenter Phase 2, Randomized, Double-Blind, Efficacy and Safety Study of Enzalutamide vs. Bicalutamide in Men With Prostate Cancer Who Have Failed Primary Androgen Deprivation Therapy

Category & Conditions: Cancer
Medicine: Xtandi (enzalutamide)
ClinicalTrials.gov Identifier (NCT): NCT01664923
Protocol ID: C3431014
    Share
PrintDownload
Open Plain Language Summary Result: Click here